← Back to Search

Social Robot

Social Robot for Alzheimer's Disease

N/A
Waitlist Available
Research Sponsored by DreamFace Technologies, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome.
Awards & highlights

Study Summary

This study is evaluating whether a robot can help people with Alzheimer's disease.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the patient health questionnaire-9 will be administered three times during the 8-10 week period. the score is between 0 and 27. each questions is scored between "0" (not at all) to "3" (nearly every day). a higher score is a worse outcome. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amyloid-Beta - Alzheimer's disease
Conversation Time
Facial Expression
+5 more
Secondary outcome measures
PHQ-9
SLUMS score

Trial Design

1Treatment groups
Experimental Treatment
Group I: Robot IntervetnionExperimental Treatment1 Intervention
Participants in this Arm will interact with Ryan Companionbot.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Robot
2021
N/A
~20

Find a Location

Who is running the clinical trial?

DreamFace Technologies, LLCLead Sponsor
2 Previous Clinical Trials
28 Total Patients Enrolled
Stephanie Melgar, BSStudy DirectorUniversity of Denver/ DFT

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025